Summary

Chronic Disease Management Market Size
The global chronic disease management market size was valued at $6.67 billion in 2025 and is projected to reach $15.42 billion by 2031, growing at a CAGR of 15.0% during the forecast period.

Chronic Disease Management Market Overview
Chronic disease management (CDM) is a comprehensive approach to healthcare that focuses on the long-term management of chronic conditions such as diabetes, hypertension, and heart disease. This strategy emphasizes the coordination of care, which includes regular screenings, check-ups, patient education, and the monitoring of treatment plans. The primary goal of CDM is to improve patient outcomes and enhance the quality of life for individuals living with chronic illnesses.

Effective chronic disease management can significantly reduce healthcare costs by preventing complications and minimizing the harshness of diseases that often require costly interventions. By focusing on proactive care, CDM helps in managing symptoms and preventing hospitalizations, leading to a more efficient use of healthcare resources. This not only benefits patients but also contributes to the overall improvement of public health.

Companies can reap substantial benefits from implementing chronic disease management programs within their workforce. Healthier employees tend to be more productive, leading to enhanced performance and reduced absenteeism. Furthermore, by investing in the health of their employees through proactive disease management strategies, businesses can lower insurance premiums and healthcare expenditures. This investment fosters a more engaged and efficient workforce, ultimately contributing to the company's bottom line.

Chronic Disease Management Market Dynamics
The chronic disease management market is expected to witness significant growth in the future due to the increasing prevalence of chronic diseases, growing geriatric population, and advancements in healthcare infrastructure and initiatives by government organizations to support chronic disease management. However, the high cost of chronic disease management services, security concerns with cloud-based chronic disease management solutions, and lack of skilled professionals are restraining the growth of the market.

Furthermore, surge in novel technological advancements, rising healthcare expenditure, and growth in medical tourism sector are the key trends propelling the chronic disease management market.

Increasing Prevalence of Chronic Diseasesis Driving the Chronic Disease Management Market
The increasing prevalence of chronic diseases is significantly impacting the chronic disease management market, by driving demand for innovative solutions and services aimed at improving patient outcomes.
• For example, the World Health Organization (WHO) has reported that chronic diseases account for approximately 60% of global deaths and 43% of the global disease burden, highlighting the urgent need for effective management strategies. This growing awareness has led to initiatives such as the U.S. Centers for Medicare and Medicaid Services (CMS) providing reimbursement policies for chronic care management, which allows healthcare providers to receive compensation for managing patients with chronic conditions. As of 2022, physicians and non-physicians can generate invoices for chronic care management, potentially earning over $2,000 per month for managing about 50 patients.
• Additionally, companies like Biofourmis launched Bioformis Care in February 2022, a service designed to deliver high-quality remote care to patients with chronic diseases, leveraging advanced technology to enhance patient engagement and treatment adherence.
• Similarly, in March 2022, Phablecare, an Indian health tech company, acquired Fused Training to strengthen its Type 1 diabetes vertical, showcasing how companies are expanding their capabilities to address the growing demand for chronic disease management solutions.

By End-User, the Healthcare ProviderSegment is projected to be the Largest Segment in the Chronic Disease Management Market
Healthcare Provider is the largest segment in the chronic disease management market, driven by the increasing prevalence of chronic diseases, advancements in healthcare technology, and supportive government initiatives. Companies like IBM have been actively involved in developing AI-driven solutions for chronic disease management, enhancing the capacity of healthcare providers to deliver personalized care. Additionally, the Agency for Healthcare Research and Quality (AHRQ) has funded numerous projects aimed at integrating health IT into chronic disease management programs, which improves care coordination and patient outcomes.
• For example, AHRQ's initiatives focus on using electronic health records and telehealth solutions to facilitate better management of chronic conditions, thereby empowering healthcare providers to improve their service delivery.
As the geriatric population continues to grow, with projections indicating that by 2030, one in five Americans will be 65 or older, the demand for healthcare providers equipped to manage chronic diseases is expected to rise significantly, further driving growth in this segment.

By Geography, North AmericaHolds the Largest Share in the Market Revenue
North America holds the largest share of the chronic disease management market, driven by the rising prevalence of chronic diseases, an aging population, and increased healthcare spending. This growth is largely attributed to the increasing incidence of conditions such as diabetes and cardiovascular diseases, which necessitate ongoing management and support.
• For instance, in 2021, the United States spent over 2% more on healthcare, totaling around USD 4 trillion, which reflects the commitment to improving healthcare access and quality for individuals with chronic conditions.
Government initiatives, such as the Healthcare Navigator program developed by the American Health Data Institute, aim to reduce healthcare expenditures by enhancing self-care and ensuring timely preventive care.
• Additionally, companies like Pegasystems have launched solutions like Pega Chronic Care Management to help healthcare organizations manage chronic conditions more effectively.
Furthermore, the integration of advanced technologies, such as AI and cloud-based solutions, is enabling better patient engagement and data management, further fueling the demand for chronic disease management services in the region.

Key Target Audience:
• Healthcare Providers
• Healthcare Payers
• Patients
• Technology Companies
• Government Organizations

List of the Key Players Profiled in the Report Includes:
• TriZetto Corporation
• IBM
• Pegasystems Inc.
• EXL Healthcare
• AxisPoint Health
• Wellcentive, Inc.
• Medecision, Inc.
• i2i Systems, Inc.
• HealthSmart Holdings, Inc.
• Allscripts Healthcare Solutions, Inc.
• ZeOmega Inc.
• Epic Corporation Inc.
• Harmony Information Systems, Inc.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Type:
• Solution
• Services

Market by, Service Type:
• Consulting Service
• Educational Service
• Implementation Service
• Other Service Types

Market by, Solution Type:
• Cloud-Based Solution
• On-Premise Solution
• Web-Based

Market by, Application:
• Arthritis
• Asthma
• Cancer
• Cardiovascular Diseases (CVD)
• Chronic Obstructive Pulmonary Disorders (COPD)
• Diabetes
• Other Applications

Market by, End-User:
• Healthcare Providers
• Healthcare Payers
• Other End-Users

Market by, Geography:
The chronic disease management market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Chronic Disease Management Market by, Type
6.1 Overview
6.2 Solution
6.3 Services

7 Global Chronic Disease Management Market by, Service Type
7.1 Overview
7.2 Consulting Service
7.3 Educational Service
7.4 Implementation Service
7.5 Other Service Types

8 Global Chronic Disease Management Market by, Solution Type
8.1 Overview
8.2 Cloud-Based Solution
8.3 On-Premise Solution
8.4 Web-Based

9 Global Chronic Disease Management Market by, Application
9.1 Overview
9.2 Arthritis
9.3 Asthma
9.4 Cancer
9.5 Cardiovascular Diseases (CVD)
9.6 Chronic Obstructive Pulmonary Disorders (COPD)
9.7 Diabetes
9.8 Other Applications

10 Global Chronic Disease Management Market by, End-User
10.1 Overview
10.2 Healthcare Providers
10.3 Healthcare Payers
10.4 Other End-Users

11 Global Chronic Disease Management Market by, Geography
11.1 Overview
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 New Zealand
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 UAE
11.6.2 Saudi Arabia
11.6.3 Qatar
11.6.4 Iran
11.6.5 South Africa
11.6.6 Rest of Middle East & Africa

12 Key Developments

13 Company Profiling
13.1 TriZetto Corporation
13.1.1 Business Overview
13.1.2 Product/Service Offering
13.1.3 Financial Overview
13.1.4 SWOT Analysis
13.1.5 Key Activities
13.2 IBM
13.3 Pegasystems Inc.
13.4 EXL Healthcare
13.5 AxisPoint Health
13.6 Wellcentive, Inc.
13.7 Medecision, Inc.
13.8 i2i Systems, Inc.
13.9 HealthSmart Holdings, Inc.
13.10 Allscripts Healthcare Solutions, Inc.
13.11 ZeOmega Inc.
13.12 Epic Corporation Inc.
13.13 Harmony Information Systems, Inc.